CODX buy NOW around 1.1usd - PUMP and DUMP - go to the MOON
BUY CODX = 1.1$
STOP=0.7$
TARGET1=2.9$ R=4
TARGET2=3.8$ R=7
TARGET3=5.1$ R=10
Chart 1 month big big level and base = 0.8$ to 1.1$
NEXT level 3.0$ usd
CODX is setting up to be a major player in the extremely “Profitable” $100Bil Biotechnology sector focusing on “Cancer Detection” using its patented CoPrimer™ technology with applications in Liquid Biopsy and companion diagnostic tests.
CODX just announced exciting news of favorable results on a study to detect cancer mutations using its patented CoPrimer™ technology, with applications in liquid biopsy and companion diagnostic tests.
Co-Diagnostics Disrupting Multi-Billion Dollar Biotech Sector With State-Of-The-Art Patented CoPrimers Providing High-Performance Detection of Cancer Mutations in Liquid Biopsy Samples Co-Diagnostics Inc. looks to be moving forward in a record-breaking pace...
I believe at just $1.10 this NASDAQ biotech stock is seriously undervalued.
Look at one of CODX biggest rivals biotech Giant Illumina it trades at $286 dollars per share, another rival to look at is Myriad Genetics it trades at $25 dollars per share.
One of CODX biggest rivals is likely biotech giant Illumina which is a “Cancer Detection Stock.” Illumina trades at $286 dollars per share, and drew over $100Mil from Bill Gates, Jeff Bezos and others to launch Grail.
CODX buy NOW around 1.1usd - PUMP and DUMP - go to the MOON
STOP=0.7$
TARGET1=2.9$ R=4
TARGET2=3.8$ R=7
TARGET3=5.1$ R=10
Chart 1 month big big level and base = 0.8$ to 1.1$
NEXT level 3.0$ usd
CODX is setting up to be a major player in the extremely “Profitable” $100Bil Biotechnology sector focusing on “Cancer Detection” using its patented CoPrimer™ technology with applications in Liquid Biopsy and companion diagnostic tests.
CODX just announced exciting news of favorable results on a study to detect cancer mutations using its patented CoPrimer™ technology, with applications in liquid biopsy and companion diagnostic tests.
Co-Diagnostics Disrupting Multi-Billion Dollar Biotech Sector With State-Of-The-Art Patented CoPrimers Providing High-Performance Detection of Cancer Mutations in Liquid Biopsy Samples Co-Diagnostics Inc. looks to be moving forward in a record-breaking pace...
I believe at just $1.10 this NASDAQ biotech stock is seriously undervalued.
Look at one of CODX biggest rivals biotech Giant Illumina it trades at $286 dollars per share, another rival to look at is Myriad Genetics it trades at $25 dollars per share.
One of CODX biggest rivals is likely biotech giant Illumina which is a “Cancer Detection Stock.” Illumina trades at $286 dollars per share, and drew over $100Mil from Bill Gates, Jeff Bezos and others to launch Grail.
